drug · small molecule
patient view →Drug for Unspecified Dermatological Disorders
Phase 1updated 2mo agoby TBT Pharma Inc🔗 ChEMBL
Phase 1community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 16 approved and 67 investigational indications.
targets
Neutrophil collagenaseInterstitial collagenaseBacterial 70S ribosomeCollagenase 3Matrilysin
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that